Alemtuzumab is not superior to basiliximab to prevent acute antibody-mediated rejection (AMR) after simultaneous pancreas-kidney transplantation

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Pirsch, JD; Pascual, J; Sasmaniego, MD; Torrealba, JR; Odorico, JS; Becker, YT; Fernandez, LA; Knechtle, SJ; Sollinger, HW

Published Date

  • September 1, 2007

Published In

Volume / Issue

  • 14 / 5

Start / End Page

  • 381 - 381

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0908-665X

Conference Name

  • Joint Meeting of the International-Xenotransplantation-Association/International-Pancrcas-and-Islet-Transplant-Association/Cell-Transplant-Society

Conference Location

  • Minneapolis, MN

Conference Start Date

  • September 15, 2007

Conference End Date

  • September 20, 2007